Top compounds associated with response to MARK4


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC -0.094 0.02
mRNA avicin D CTRPv2 pan-cancer AAC 0.13 0.02
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.094 0.02
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.076 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.02
mRNA AA-COCF3 CTRPv2 pan-cancer AAC 0.085 0.02
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.069 0.02
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
Download CSV